35.56
price down icon0.64%   -0.23
 
loading
Indivior Plc stock is traded at $35.56, with a volume of 2.84M. It is down -0.64% in the last 24 hours and up +18.14% over the past month. Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$35.79
Open:
$36.3
24h Volume:
2.84M
Relative Volume:
1.32
Market Cap:
$4.45B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
3,556.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+1.25%
1M Performance:
+18.14%
6M Performance:
+155.28%
1Y Performance:
+209.22%
1-Day Range:
Value
$35.54
$36.55
1-Week Range:
Value
$35.40
$38.00
52-Week Range:
Value
$7.62
$38.00

Indivior Plc Stock (INDV) Company Profile

Name
Name
Indivior Plc
Name
Phone
804-379-1090
Name
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Name
Employee
1,051
Name
Twitter
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
INDV's Discussions on Twitter

Compare INDV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
INDV
Indivior Plc
35.56 4.47B 1.12B 5.00M -383.00M 0.01
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
118.66 51.85B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.33 45.46B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.52 42.70B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
29.79 34.62B 16.88B 666.71M 251.19M 0.6132
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
493.99 21.03B 3.08B 1.24B 1.07B 25.61

Indivior Plc Stock (INDV) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-06-25 Initiated H.C. Wainwright Buy
Jul-22-25 Resumed Jefferies Buy
Jan-28-25 Initiated Rodman & Renshaw Buy
Jul-23-24 Initiated Piper Sandler Overweight
Apr-03-24 Initiated Craig Hallum Buy
Jul-13-23 Initiated Northland Capital Outperform
View All

Indivior Plc Stock (INDV) Latest News

pulisher
Dec 09, 2025

Indivior (INDV) Is Up 8.9% After Newtyn Ups Stake And EBITDA Guidance RisesHas The Bull Case Changed? - Sahm

Dec 09, 2025
pulisher
Dec 08, 2025

Indivior stock hits all-time high at 37.72 USD By Investing.com - Investing.com Canada

Dec 08, 2025
pulisher
Dec 08, 2025

What drives Indivior PLC stock priceWeekly Market Snapshot & Double Or Triple Profits - earlytimes.in

Dec 08, 2025
pulisher
Dec 08, 2025

Indivior stock hits all-time high at 37.72 USD - Investing.com

Dec 08, 2025
pulisher
Dec 07, 2025

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge - sharewise.com

Dec 07, 2025
pulisher
Dec 06, 2025

What analysts say about Indivior PLC stockResistance Zone Identification & Big Gains Low Cost - earlytimes.in

Dec 06, 2025
pulisher
Dec 05, 2025

Is Indivior PLC stock a dividend growth opportunity2025 Analyst Calls & Verified Entry Point Detection - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Indivior PLC Stock Analysis and ForecastTrading Volume Surges & Low Risk Trading Ideas - earlytimes.in

Dec 04, 2025
pulisher
Dec 04, 2025

Indivior Shares Move Above Key Trend Level - Kalkine Media

Dec 04, 2025
pulisher
Dec 04, 2025

How Indivior PLC stock reacts to inflationary pressuresQuarterly Trade Review & Growth Focused Entry Reports - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Indivior PLC stock weather global recessionJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is Indivior PLC (2IVB) stock attractive post correctionJuly 2025 News Drivers & Real-Time Buy Signal Alerts - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

Can Indivior PLC stock sustain institutional interest2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Indivior (INDV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025
pulisher
Dec 01, 2025

Is Indivior PLC a good long term investmentMarket Sentiment Indicators & Rapid Wealth Accumulation - earlytimes.in

Dec 01, 2025
pulisher
Nov 28, 2025

Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation (PR Newswire) - Aktiellt

Nov 28, 2025
pulisher
Nov 28, 2025

Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment (PR Newswire) - Aktiellt

Nov 28, 2025
pulisher
Nov 28, 2025

Indivior PLC (INDV) Stock Price Today | Live Chart & News - Traders Union

Nov 28, 2025
pulisher
Nov 28, 2025

Indivior stock hits all-time high of 33.72 USD By Investing.com - Investing.com Australia

Nov 28, 2025
pulisher
Nov 28, 2025

Indivior stock hits all-time high of 33.72 USD - Investing.com

Nov 28, 2025
pulisher
Nov 26, 2025

Piper Sandler Healthcare Conference - MarketScreener

Nov 26, 2025
pulisher
Nov 24, 2025

INDVIndivior Latest Stock News & Market Updates - Stock Titan

Nov 24, 2025
pulisher
Nov 24, 2025

Rodman & Renshaw sets $16 target on Indivior stock with Buy rating - MSN

Nov 24, 2025
pulisher
Nov 23, 2025

Indivior PLC (INDV) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union

Nov 23, 2025
pulisher
Nov 23, 2025

Indivior PLC (INDV) Stock Price Prediction for 2026, 2030-2040 - Traders Union

Nov 23, 2025
pulisher
Nov 23, 2025

Indivior resolving legacy DOJ matter removes ‘major overhang,’ says Northland - MSN

Nov 23, 2025
pulisher
Nov 23, 2025

Indivior price target raised to $41 from $27 at Piper Sandler - MSN

Nov 23, 2025
pulisher
Nov 22, 2025

Indivior (INDV) Resolves Major Legal Issue, Outlook Remains Posi - GuruFocus

Nov 22, 2025
pulisher
Nov 21, 2025

Indivior Concludes Legacy U.S. Department of Justice Matter - The Malaysian Reserve

Nov 21, 2025
pulisher
Nov 21, 2025

Indivior Concludes DOJ Settlement with Final Payment - The Globe and Mail

Nov 21, 2025
pulisher
Nov 21, 2025

Indivior pays $295 million to conclude legacy DOJ matter By Investing.com - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

Can Indivior PLC (2IVB) stock sustain double digit ROEAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Indivior (INDV) Is Up 6.5% After Settling DOJ Liability and Ending Resolution Agreement – Has The Bull Case Changed? - simplywall.st

Nov 21, 2025
pulisher
Nov 21, 2025

How Indivior PLC stock valuations compare to rivalsNew Guidance & Accurate Buy Signal Notifications - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge - Yahoo Finance

Nov 21, 2025
pulisher
Nov 20, 2025

Indivior concludes legacy U.S. Department of Justice matter - TipRanks

Nov 20, 2025
pulisher
Nov 20, 2025

Indivior pays $295 million to conclude legacy DOJ matter - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Indivior (INDV) Resolves DOJ Case with $295M Payment - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

Will Indivior PLC (2IVB) stock draw ESG focused fundsWeekly Volume Report & AI Driven Price Predictions - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference - BioSpace

Nov 20, 2025
pulisher
Nov 20, 2025

Leading vs lagging indicators on Indivior PLC performance2025 Price Momentum & Short-Term Swing Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why analysts maintain buy rating on Indivior PLC (2IVB) stock2025 Technical Patterns & AI Driven Price Predictions - newser.com

Nov 20, 2025

Indivior Plc Stock (INDV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.21
price down icon 1.48%
$21.29
price up icon 0.09%
drug_manufacturers_specialty_generic RDY
$14.02
price down icon 0.50%
$11.65
price up icon 0.52%
$152.80
price down icon 1.26%
$493.99
price up icon 1.12%
Cap:     |  Volume (24h):